Last deal

$32.M
Local Amount - INR 2.7B

Amount

Post-IPO Equity

Stage

21.02.2022

Date

1

all rounds

$32.M

Total amount

General

About Company
Jagsonpal Pharmaceuticals is a pharma company that specializes in developing and manufacturing bulk drugs & pharmaceutical formulations.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Jagsonpal

founded date

01.01.1964

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

With over 50 years of experience, Jagsonpal Pharmaceuticals Ltd is a premier pharmaceutical company in India that develops and manufactures active pharmaceutical ingredients and formulations such as Capsule and Tablet. The company has a single reporting segment, the Pharmaceutical segment, and derives its revenue from the same. Its brands include Lycored, Maintane, Metadec, Metabol, Doxypal DR, and others. Jagsonpal has substantial research and development, manufacturing, marketing, and distribution facilities, and is committed to sustainable growth through market penetration, expansion, and multi-national expansion. The firm has a global reach with affiliates, joint ventures, and representative offices in countries such as Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt, and Vietnam.